JELD-WEN Holding, Inc.
For the period ended Sep 27, 2025. Filed Nov 6, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 27, 2025 · Filed Nov 6, 2025
JELD$1.15+12.7%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Equity
| Three Months Ended | |||||
|---|---|---|---|---|---|
| September 27, 2025 · September 28, 2024 | |||||
| (amounts in thousands, except share and per share amounts) · Shares · Amount · Shares · Amount | |||||
| Preferred stock, $0.01 par value per share | — | $— | — | $— | |
| Common stock, $0.01 par value per share | |||||
| Balance at beginning of period | 85,338,335 | $853 | 84,511,647 | $845 | |
| Shares issued for exercise/vesting of share-based compensation awards | 88,242 | 1 | 129,761 | 1 | |
| Shares surrendered for tax obligations for employee share-based transactions | (12,772) | — | (23,890) | — | |
| Balance at period end | 85,413,805 | $854 | 84,617,518 | $846 | |
| Additional paid-in capital | |||||
| Balance at beginning of period | $776,680 | $764,603 | |||
| Shares issued for exercise/vesting of share-based compensation awards | (1) | 375 | |||
| Shares surrendered for tax obligations for employee share-based transactions | (23) | (381) | |||
| Amortization of share-based compensation | 4,267 | 2,459 | |||
| Balance at period end | 780,923 | 767,056 | |||
| Employee stock notes | |||||
| Balance at beginning of period | (673) | (673) | |||
| Net issuances, payments and accrued interest on notes | — | — | |||
| Balance at period end | (673) | (673) | |||
| Balance at period end | $780,250 | $766,383 | |||
| (Accumulated deficit) retained earnings | |||||
| Balance at beginning of period | $(232,016) | $122,446 | |||
| Net loss | (367,598) | (74,402) | |||
| Balance at period end | $(599,614) | $48,044 | |||
| Accumulated other comprehensive loss | |||||
| Balance at beginning of period | $(67,722) | $(117,196) | |||
| Foreign currency adjustments | 96 | 23,246 | |||
| Unrealized gain on foreign currency hedges | 206 | — | |||
| Unrealized gain (loss) on interest rate hedges | 48 | (971) | |||
| Unrealized loss on commodity hedges | (99) | — | |||
| Net actuarial pension loss | (80) | (62) | |||
| Balance at period end | $(67,551) | $(94,983) | |||
| Total shareholders’ equity at period end | $113,939 | $720,290 | |||
CONSOLIDATED STATEMENTS OF EQUITY
| Nine Months Ended | |||||
|---|---|---|---|---|---|
| September 27, 2025 · September 28, 2024 | |||||
| (amounts in thousands, except share and per share amounts) · Shares · Amount · Shares · Amount | |||||
| Preferred stock, $0.01 par value per share | — | $— | — | $— | |
| Common stock, $0.01 par value per share | |||||
| Balance at beginning of period | 84,653,408 | $846 | 85,309,220 | $853 | |
| Shares issued for exercise/vesting of share-based compensation awards | 859,606 | 9 | 976,260 | 10 | |
| Shares repurchased | — | — | (1,600,000) | (16) | |
| Shares surrendered for tax obligations for employee share-based transactions | (99,209) | (1) | (67,962) | (1) | |
| Balance at period end | 85,413,805 | $854 | 84,617,518 | $846 | |
| Additional paid-in capital | |||||
| Balance at beginning of period | $769,737 | $752,844 | |||
| Shares issued for exercise/vesting of share-based compensation awards | (5) | 2,866 | |||
| Shares surrendered for tax obligations for employee share-based transactions | (737) | (1,246) | |||
| Amortization of share-based compensation | 11,928 | 12,592 | |||
| Balance at period end | 780,923 | 767,056 | |||
| Employee stock notes | |||||
| Balance at beginning of period | (673) | (673) | |||
| Net issuances, payments and accrued interest on notes | — | — | |||
| Balance at period end | (673) | (673) | |||
| Balance at period end | $780,250 | $766,383 | |||
| (Accumulated deficit) retained earnings | |||||
| Balance at beginning of period | $(20,353) | $192,931 | |||
| Shares repurchased | — | (24,264) | |||
| Net loss | (579,261) | (120,623) | |||
| Balance at period end | $(599,614) | $48,044 | |||
| Accumulated other comprehensive loss | |||||
| Balance at beginning of period | $(129,495) | $(95,310) | |||
| Foreign currency adjustments | 62,752 | 1,004 | |||
| Unrealized loss on foreign currency hedges | (597) | — | |||
| Unrealized gain (loss) on interest rate hedges | 73 | (645) | |||
| Net actuarial pension loss | (284) | (32) | |||
| Balance at period end | $(67,551) | $(94,983) | |||
| Total shareholders’ equity at period end | $113,939 | $720,290 | |||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.